DRUGS - Protein Synth Inhibitors [Wk 4 FOM] Flashcards
Pair each Protein Synthesis Inhibitor with the proper prokaryotic subunit affected
30S inhibitors
- Aminoglycosides
- Tetracycline
50S inhibitors
- Chloramphenicol
- Clindamycin
- Linezolid
- Macrolides
- Streptogramins
Identify the 1) Mechanism of inhibition, 2) Spectrum of activity, 3) Mechanism of resistance, and 4) Adverse effects associated with the following agent(s):
Linezolid
• MECHANISM
Binds to 23s rRNA on 50s unit of ribosome, inhibits initiation of tln
• SPECTRUM
Reserved for Grm+ (MRSA, VRE)
• RESISTANCE Alters target (23s rRNA)
• SIDE EFFECTS
- Bone Marrow Suppression
Name two additional qualities that make Linezolid an excellent pharmaceutical
- No Cross-Resistance
- Excellent Bioavailability (even better than Vanco)
Identify the 1) Mechanism of inhibition, 2) Spectrum of activity, 3) Mechanism of resistance, and 4) Adverse effects associated with the following agent(s):
Aminoglycosides Class:
- Gentamycin
- Neomycin
- Tobramycin
- Streptomycin
- Amikacin
• MECHANISM
Prevents initiation complex formation, misreading of mRNA, early termination;
*Note: Unique: Can stop initiation, elongation, and termination of tln
• SPECTRUM
Gram – aerobic only (eg Pseudomonas)
• RESISTANCE
1. Intrinsic: drug can’t enter bac
2. Acquired: drug target methylation, enzyme inactivation of drug
*Note: Amikacin – less susceptible to enzyme inactivation
- SIDE EFFECTS
- Tubular Necrosis – nephro/oto toxicity,
- teratogen – hearing loss in fetus
- IV administration
Why are the Aminoglycosides coupled with Penicillins?
This coupling increases permeability of Grm + cell wall so aminoglycoside can enter the cell (Yes, this is the only way you’re going to get Aminiglycosides to be active against gm+ agents)
Identify the 1) Mechanism of inhibition, 2) Spectrum of activity, 3) Mechanism of resistance, and 4) Adverse effects associated with the following agent(s):
Tetracyclines Class:
- Tetracycline
- Doxycycline
- Demeclocycline
- Minocycline
• MECHANISM
Bind to 30s unit – prevents tRNA attachment
- SPECTRUM
- BROAD: B. burgdorferi (lyme), H. pylori (ulcer), M. pneumoniae
• RESISTANCE
- Intrinsic: dec. drug uptake
- Acquired: Efflux!, alter target
• SIDE EFFECTS
- Chelates with metal ions (dec. absorption of drug)
- GI irritation
- photosensitivity
- teeth discoloration
- Inhibits bone growth – children
- DO NOT GIVE TO: Pregnant women, children under 8
Identify the 1) Mechanism of inhibition, 2) Spectrum of activity, 3) Mechanism of resistance, and 4) Adverse effects associated with the following agent(s):
Macrolides Class:
- Erythromycin
- Azithromycin
- Clarithromycin
• MECHANISM
Binds to 23s rRNA on 50s unit – inhibits tRNA translocation
• SPECTRUM
BROAD (Respiratory Pathogens, Chlamydia, Mycobacteria)
• RESISTANCE
Efflux!
Drug target methylation
Esterases alter drug
**CROSS-RESISTANCE WITH Clindamycin & Streptogramins
• SIDE EFFECTS
- GI irritation
- Hepatic Failure
- Prolonged QT interval
- Inhibit Cyt P450
- drug-drug interactions
- DO NOT GIVE Clarithromycin TO: Pregnant women
Identify the 1) Mechanism of inhibition, 2) Spectrum of activity, 3) Mechanism of resistance, and 4) Adverse effects associated with the following agent(s):
Chloramphenicol
• MECHANISM
Binds 50s unit – inhibits peptide bond formation• SPECTRUM
• SPECTRUM
Extended Limit use(due to side effects)
Can cross B-B barrier, treat meningitis
• RESISTANCE
Acetyltransferase modifies drug
• SIDE EFFECTS
- TOXIC side effects!!
Bone marrow depression and aplastic anemia - DO NOT GIVE TO: Pregnant women, children under 8
- Gray Baby
What is Gray Baby Syndrome, and what causes it?
Gray Baby Syndrome: infants lack the transferase needed to break down drug, in this case CHLORAMPHENICOL, high levels of drug accumulate, results in cardio and respiratory collapse
Identify the 1) Mechanism of inhibition, 2) Spectrum of activity, 3) Mechanism of resistance, and 4) Adverse effects associated with the following agent(s):
Clindamycin
• MECHANISM
Binds to 23s rRNA on 50s unit – inhibits tRNA translocation
• SPECTRUM
BROAD (Aerobic and anaerobic, acne)
• RESISTANCE
Alter/methylate ribosome target, adenylase modifies drug
**CROSS-RESISTANCE WITH Macrolides & Streptogramins
• SIDE EFFECTS
- Hypersensitivity – rash, fever
- Superinfection – C. diff
- Diarrhea, abdominal pain, mucus/blood in stool
Identify the 1) Mechanism of inhibition, 2) Spectrum of activity, 3) Mechanism of resistance, and 4) Adverse effects associated with the following agent(s):
Streptogramins:
Quinupristin/
Dalfopristin
(together)
• MECHANISM
Binds to 23s rRNA on 50s unit – inhibits tRNA translocation
• SPECTRUM
Reserved for Grm + MRSA, VRE
• RESISTANCE
Alter/methylate ribosome target, enzymes modify drug,
Efflux!
**CROSS-RESISTANCE WITH Macrolides & Clindamycin
• SIDE EFFECTS
- Arthralgias and myalgias
- Inhibits Cyt P450, drug – drug interactions
RESISTANCE MECHANISMS #1: Drugs that don’t reach their target due to either a) decreased uptake, or b) efflux
• Primarily decreased uptake (it’s a TASC! -or- SuCh a TeAm!)
- o Tetracyclines
- o Aminoglycosides
- o Sulfonamides
- o Chloramphenicol
• Increased efflux (“To create Flux: set a Magnetic Strip on the Floor, and then get yourSulf a newspaper; read it A–>Z while Cepping Tetley)
- Quinupristin/dalfopristin
- Macrolides
- Fluoroquinolones
- Aztreonam
- Cephalosporins
- Tetracyclines (most impt), minocycline the exception
- Sulfonamides
RESISTANCE MECHANISMS #2: Drugs whose targets are altered due to either a) direct alteration, or b) upregulation of target/substrate
• Altered Target
- o Beta-lactams – altered penicillin binding proteins (MRSA)
- o Vancomycin- altered target
- o Rifampin - DNA dependent RNA polymerase
- o Fluoroquinolones - DNA topoisomerase II or IV
- o Sulfonamides - Dihydropteroate synthetase
- o Trimethoprim - Dihydrofolate reductase
- o Linezolid – altered ribosome
- o Aminoglycosides – altered ribosome (uncommon)
- o Erythromycin, clindamycin, quinupristin/dalfopristin – methyltransferase modified ribosome
- o Tetracyclines – production of proteins that interfere with ribosomal binding
• Upregulation of target or its substrate
- o Sulfonamides- Increased levels of para-amino benzoic acid synthesis
RESISTANCE MECHANISMS #3: Drugs that are not active primarily due to enzymatic alteration of the antibiotic, and
- o Penicillins beta-lactamases
- o Cephalosporins beta-lactamases
- o Aminoglycosides Amikacin most resistant, acetyl group
- o Chloramphenicol Acetyltransferase action
- o Tetracyclines minor- acetylation
- o Macrolides bacterial esterases
- o Clindamycin adenylation
- **o quinupristin/dalfopristin **
- o metronidazole decreased drug activation
Name the drugs where resistance RARELY occurs
- Bacitracin
- Polymyxins